HomeANEB • NASDAQ
add
Anebulo Pharmaceuticals Inc
Previous close
$1.44
Day range
$1.44 - $1.59
Year range
$1.25 - $3.30
Market cap
37.34M USD
Avg Volume
5.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.41M | -5.17% |
Net income | -2.20M | 11.29% |
Net profit margin | — | — |
Earnings per share | -0.08 | 20.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.40M | -83.52% |
Total assets | 2.47M | -72.72% |
Total liabilities | 569.22K | -20.56% |
Total equity | 1.90M | — |
Shares outstanding | 25.93M | — |
Price to book | 20.57 | — |
Return on assets | -184.38% | — |
Return on capital | -211.17% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.20M | 11.29% |
Cash from operations | -1.69M | 38.02% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.69M | 38.02% |
Free cash flow | -1.03M | 43.67% |
About
Founded
2020
Headquarters
Website
Employees
3
